| Literature DB >> 23050135 |
Gabriele Ricci1, Marco Assenza, Marco Barreca, Gianluca Liotta, Livio Paganelli, Angelo Serao, Giovanni Tufodandria, Pierluigi Marini.
Abstract
Background. Parathyroid carcinoma is an infrequent clinical entity whose diagnosis is very challenge. Indeed a pre-operative or intraoperative diagnosis of parathyroid carcinoma is reported in less than half cases described in the literature. Patients and Methods. A systematic review of pathological reports of our secondary referral hospital was done. From 2003 to 2011 one hundred and forty-four patients were operated for hyperparathyroidism. One patient with atypical adenoma and three patients with parathyroid carcinoma were included in this paper. Results. An en bloc resection of the tumor was performed in three patients. Two of this patients with diagnosis of parathyroid carcinoma are alive with no evidence of recurrence or metastasis, respectively, 48 and 60 months after the operation; one patient with diagnosis of atypical adenoma died for other disease 16 months after the operation. In the last patient a simple parathyroidectomy was performed. After that histology revealed the diagnosis of parathyroid carcinoma the patient underwent reoperation for left hemithyroidectomy and central compartment lymph node clearance. After 30 months a lung lobectomy was done due to metastasis. Conclusion. Parathyroid carcinoma should be considered in the differential diagnosis of PTH-dependent hypercalcemia because optional outcomes are associated with complete resection of the tumor at the time of initial operation.Entities:
Year: 2012 PMID: 23050135 PMCID: PMC3459246 DOI: 10.1155/2012/649148
Source DB: PubMed Journal: Int J Surg Oncol ISSN: 2090-1402
Diagnoses in primary hyperthyroidism.
| Diagnosis |
| % |
|---|---|---|
| Adenoma | 123 | 85,41% |
| Hyperplasia | 17 | 11,80% |
| Carcinoma | 3 | 2,08% |
| Atypical adenoma | 1 | 0,69% |
Main clinical features of patients with parathyroid carcinoma (PC) and atypical adenoma (AA).
| Patient 1 (PC) | Patient 2 (PC) | Patient 3 (PC) | Patient 4 (AA) | |
|---|---|---|---|---|
| Age | 46 | 69 | 64 | 54 |
| Gender | F | M | M | M |
| Symptoms | Renal + | Renal + | Renal + | Renal − |
| Palpable mass | No | No | Yes | Yes |
| Calcium (mg/dL) | 14,0 | 13,0 | 14,2 | 13,2 |
| PTH (pg/mL) | 898 | 184 | 620 | 475 |
| Type of resection |
| (1) MIVAP |
|
|
| Affected gland | Left superior | Left superior | Left inferior | Right inferior |
| Tumor size | 2,7 × 1,4 × 2,5 cm | 1,9 × 1,7 × 1,4 cm | 3,6 × 2 × 2,7 cm | 3 × 1,7 × 1,2 cm |
| Outcome | Alive, no evidence of disease at 60 months of followup | Alive, surgically treated lung metastasis, rise in calcium/PTH levels without evidence of recurrence at imaging investigations at 36 months of followup | Alive, no evidence of disease at 48 months of followup | Died for other disease |
Typical features of PHPT secondary to parathyroid carcinoma versus parathyroid benign disease.
| Parathyroid carcinoma | Parathyroid benign disease | |
|---|---|---|
| Average age | 48 | 55 |
| Female/male ratio | 1 : 1 | 3,5 : 1 |
| Tumor size >3 cm | Frequent | Very rare |
| Serum calcium | 14–16 mg/dL | 11-12 mg/dL |
| PTH | Markedly elevated | Mildly elevated |
| Asymptomatic | <2% | 40–80% |
| Palpable neck mass | 38% | <2% |
| Hoarseness | 1–14% | None |
| Renal and skeletal involvement | 30–50% | <5% |
| Hypercalcemic crisis | 14% | <2% |
| Intraoperative findings | Lobulated firm mass, surrounded by fibrous grayish-white capsule that adheres tenaciously to thyroid lobe or adjacent cervical tissues | Soft, oval, and brownish red |
(From ref. [1–3, 6, 9, 10]).